Orion Oyj (ORINF)
82.75
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Orion EPS Diluted (Quarterly) : 0.7515 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.7515 |
| December 31, 2025 | 2.155 |
| September 30, 2025 | 0.7974 |
| June 30, 2025 | 0.6651 |
| March 31, 2025 | 0.459 |
| December 31, 2024 | 0.5573 |
| September 30, 2024 | 1.257 |
| June 30, 2024 | 0.3984 |
| March 31, 2024 | 0.3385 |
| December 31, 2023 | 0.5754 |
| September 30, 2023 | 0.4759 |
| June 30, 2023 | 0.2823 |
| March 31, 2023 | 0.335 |
| December 31, 2022 | 0.2306 |
| September 30, 2022 | 1.394 |
| June 30, 2022 | 0.5003 |
| March 31, 2022 | 0.457 |
| December 31, 2021 | 0.2667 |
| September 30, 2021 | 0.3807 |
| June 30, 2021 | 0.4803 |
| March 31, 2021 | 0.511 |
| December 31, 2020 | 0.2164 |
| September 30, 2020 | 0.4277 |
| June 30, 2020 | 0.5927 |
| March 31, 2020 | 0.5284 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.3562 |
| September 30, 2019 | 0.5666 |
| June 30, 2019 | 0.3261 |
| March 31, 2019 | 0.3454 |
| December 31, 2018 | 0.4307 |
| September 30, 2018 | 0.2836 |
| June 30, 2018 | 0.485 |
| March 31, 2018 | 0.499 |
| December 31, 2017 | 0.4623 |
| September 30, 2017 | 0.3682 |
| June 30, 2017 | 0.4423 |
| March 31, 2017 | 0.5329 |
| December 31, 2016 | 0.3664 |
| September 30, 2016 | 0.5804 |
| June 30, 2016 | 0.5307 |
| March 31, 2016 | 0.4961 |
| December 31, 2015 | 0.3065 |
| September 30, 2015 | 0.3557 |
| June 30, 2015 | 0.4536 |
| March 31, 2015 | 0.5284 |
| December 31, 2014 | 0.3623 |
| September 30, 2014 | 0.4637 |
| June 30, 2014 | 0.6582 |
| March 31, 2014 | 0.507 |
| December 31, 2013 | 0.5309 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.1342 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 105.76M |
| Revenue (Quarterly) | 488.68M |
| Total Expenses (Quarterly) | 382.92M |
| Enterprise Value | 11.81B |
| Gross Profit Margin (Quarterly) | 60.81% |
| Profit Margin (Quarterly) | 21.64% |
| Earnings Yield | 5.28% |
| Operating Earnings Yield | 6.62% |
| Normalized Earnings Yield | 5.280 |